Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

(2010) H. E. Kohrt et al.   BLOOD

Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era

(2010) Marita Ziepert et al.   JOURNAL OF CLINICAL ONCOLOGY

Ten Years On — The Human Genome and Medicine

(2010) Harold Varmus   NEW ENGLAND JOURNAL OF MEDICINE

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

(2010) Christian Steidl et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal

(2010) M. P. McCormack et al.   SCIENCE

Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion

(2009) R. Houot et al.   BLOOD

Mice deficient for CD137 ligand are predisposed to develop germinal center-derived B-cell lymphoma

(2009) S. Middendorp et al.   BLOOD

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

(2009) K. Dunleavy et al.   BLOOD

A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

(2009) W. W.L. Choi et al.   CLINICAL CANCER RESEARCH

Germinal center or nongerminal center DLBCL?

(2009) Gerhard Held et al.   Nature Reviews Clinical Oncology

Molecular Outcome Prediction in Diffuse Large-B-Cell Lymphoma

(2009) Ash A. Alizadeh et al.   NEW ENGLAND JOURNAL OF MEDICINE

A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?

(2008) B. Haibe-Kains et al.   BIOINFORMATICS

Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP

(2008) R. Malumbres et al.   BLOOD

Stromal Gene Signatures in Large-B-Cell Lymphomas

(2008) G. Lenz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diffuse Large B Cell Lymphoma: From Gene Expression Profiling to Prediction of Outcome

(2007) Izidore S. Lossos   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

LMO2 Protein Expression Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy With and Without Rituximab

(2007) Yasodha Natkunam et al.   JOURNAL OF CLINICAL ONCOLOGY